Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
What does a Democratic blue wave mean for healthcare policy?
Fraud
Regulatory
Industry Voices—Where healthcare fraud enforcement goes next
A new Congress may bring closer scrutiny of how the healthcare industry is organized, owned and paid, writes Miller & Chevalier's Kevin Lowell.
Kevin Lowell
Nov 6, 2026 12:59pm
DOJ charges doctors, others in $2B healthcare fraud schemes
Oct 26, 2026 12:30pm
HHS, DOJ unveil program for self-disclosure of FCA violations
Oct 23, 2026 2:00pm
CMS defers $1.2B in Medicaid funds from California
Oct 21, 2026 12:45pm
DOJ streamlines voluntary self-disclosure of healthcare fraud
Oct 20, 2026 12:27pm
After booting 760K from ACA plans, Trump admin adds some back
Oct 16, 2026 11:18am